Related Experiment Videos
Cyclosporin A in the treatment of refractory B chronic lymphocytic leukemia (B-CLL)
E Van Den Neste1, M Maerevoet, P Martiat
1Département d'Hématologie de l'Université Catholique de Louvain, Brussels, Belgium.
Leukemia
|June 1, 1995
Abstract:
Partial tumoral responses have been described after cyclosporin A treatment in refractory B-chronic lymphocytic leukemia patients. We report the effect of this therapy in five patients prospectively treated with oral conventional dose of cyclosporin A. Antitumoral efficiency was marginal (one sustained partial response among five patients) which, added to a potential worsening of natural and therapy-related immunodepression, limits its use in this instance.